RESUMEN
This case report shows the vital importance of vigilant observation of patients after transplant. In centers where ultrasonographs are not available, exploration of the patient may be necessary to salvage a precious kidney. In the patient reported here, who received a kidney transplant at St. Nicholas Hospital in Lagos (Nigeria, Africa), reexploration resulted in an increased area for the kidney, with both improved urine output and graft function.
Asunto(s)
Trasplante de Riñón , Niño , Supervivencia de Injerto , Humanos , Riñón , Trasplante de Riñón/efectos adversos , Nigeria , Resultado del TratamientoRESUMEN
OBJECTIVES: Despite the present use ofthe laparoscopic technique for living-donor kidney nephrectomy, a search for alternative techniques continues.The aim of this study was to compare finger-assisted open donor nephrectomy versus laparoscopic donor nephrectomy. MATERIALS AND METHODS: This study included retrospective data of 95 consecutive donors in a transplant center who were under going donor nephrectomy RESULTS: Donor demographics and clinical characteristics were generally similar between treatment groups. There were fewer female donors in the finger-assisted open donor nephrectomy treatment group (70.5% vs 29.5%; P = .003), but median body mass index was similar between groups (28 vs 26 kg/m²; P = .032). Patients who received laparoscopic donor nephrectomy had longer operative duration (3.5 vs 1.2 h; P < .001), longer combined length of incision (6 vs 5 cm; P = .001), andshorter median hospital length of stay (3 vs 4 days; P < .001). A left nephrectomy was preferred in both groups. Minor postoperative complications occurred less often in the finger-assisted open donor nephrectomy group (14.7% vs 31.6%; P = .0094). Donors who received laparoscopic nephrectomy had lower glomerular filtration rate at 1 year after donation (60 vs 89 mL/min/1.73 m²; P < .001) than donors who received finger-assisted nephrectomy. However, recipients of donors of both procedures had similar glomerular filtration rate at 1 year after transplant (65 vs 69 mL/min/1.73 m²; P = .5). CONCLUSIONS: Our study demonstrated that finger-assisted open donor nephrectomy is a successful and safe alternative versus laparoscopic donor nephrectomy, providing favorable results for patients in terms of complications and outcomes.
Asunto(s)
Trasplante de Riñón , Laparoscopía , Donadores Vivos , Nefrectomía/métodos , Adulto , Femenino , Humanos , Trasplante de Riñón/efectos adversos , Laparoscopía/efectos adversos , Tiempo de Internación , Londres , Masculino , Nefrectomía/efectos adversos , Tempo Operativo , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , VirginiaRESUMEN
HIV-associated nephropathy (HIVAN) is a pathological state of the kidneys due to longstanding, uncontrolled HIV infection. With the rapid progression of HIVAN to end-stage kidney failure, there is a significant potential for renal transplantation to improve the quality of life in these patients. Numerous studies have been recently published documenting renal transplantation as a primary treatment for HIVAN. With the use of highly active antiretroviral therapy, allograft and patient survival rates of HIV-infected persons are nearly identical to those who are HIV negative. Our case study documents the successful role of renal transplantation in treating HIVAN in a 9-year-old male child.
RESUMEN
This paper relates to our transplant experiences in Third World countries. Over the years, I have started kidney transplant programs in Aden, Yemen and Abuja, Nigeria and restarted the transplant program in Khartoum, Sudan.
Asunto(s)
Países en Desarrollo , Accesibilidad a los Servicios de Salud , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Adulto , Análisis Costo-Beneficio , Países en Desarrollo/economía , Femenino , Costos de la Atención en Salud , Accesibilidad a los Servicios de Salud/economía , Disparidades en Atención de Salud , Humanos , Fallo Renal Crónico/diagnóstico , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/economía , Trasplante de Riñón/métodos , Masculino , Persona de Mediana Edad , Nigeria , Sudán , Resultado del Tratamiento , Adulto JovenRESUMEN
In order to induce liver hypertrophy to enable liver resection in patients with a small future liver remnant (FLR), various methods have been proposed in addition to portal vein embolisation (PVE). Most recently, the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique has gained significant international interest. This technique is limited by the high morbidity associated with an in situ liver splitting and the patient undergoing two open operations. We present the case of a variant ALPPS technique performed entirely laparoscopically with no major morbidity or mortality. An increased liver volume of 57.9% was seen after 14 days. This technique is feasible to perform and compares favourably to other ALPPS methods whilst gaining the advantages of laparoscopic surgery.
RESUMEN
OBJECTIVES: The prevalence of obesity is increasing rapidly and globally, yet systemic reviews on this topic are scarce. Our meta-analysis and systemic review aimed to assess how obesity affects 5 postoperative outcomes: biopsy-proven acute rejection, patient death, allograft loss, type 2 diabetes mellitus after transplant, and delayed graft function. MATERIALS AND METHODS: We evaluated peer-reviewed literature from 22 medical databases. Studies were included if they were conducted in accordance with the Meta-analysis of Observational Studies in Epidemiology criteria, only examined postoperative outcomes in adult patients, only examined the relation between recipient obesity at time of transplant and our 5 postoperative outcomes, and had a minimum score of > 5 stars on the Newcastle-Ottawa scale for nonrandomized studies. Reliable conclusions were ensured by having our studies examined against 2 internationally known scoring systems. Obesity was defined in accordance with the World Health Organization as having a body mass index of > 30 kg/m(2). All obese recipients were compared versus "healthy" recipients (body mass index of 18.5-24.9 kg/m(2)). Hazard ratios were calculated for biopsy-proven acute rejection, patient death, allograft loss, and type 2 diabetes mellitus after transplant. An odds ratio was calculated for delayed graft function. RESULTS: We assessed 21 retrospective observational studies in our meta-analysis (N = 241 381 patients). In obese transplant recipients, hazard ratios were 1.51 (95% confidence interval, 1.24-1.78) for presence of biopsy-proven acute rejection, 1.19 (95% confidence interval, 1.10-1.31) for patient death, 1.54 (95% confidence interval, 1.38-1.68) for allograft loss, and 1.01 (95% confidence interval, 0.98-1.07) for development of type 2 diabetes mellitus. The odds ratio for delayed graft function was 1.81 (95% confidence interval, 1.51-2.13). CONCLUSIONS: Our meta-analysis clearly demonstrated greater risks for obese renal transplant recipients and poorer postoperative outcomes with obesity. We confidently recommend renal transplant candidates seek medically supervised weight loss before transplant.
Asunto(s)
Enfermedades Renales/cirugía , Trasplante de Riñón/efectos adversos , Obesidad/complicaciones , Receptores de Trasplantes , Funcionamiento Retardado del Injerto/etiología , Diabetes Mellitus Tipo 2/etiología , Rechazo de Injerto/etiología , Supervivencia de Injerto , Humanos , Enfermedades Renales/complicaciones , Enfermedades Renales/diagnóstico , Enfermedades Renales/mortalidad , Trasplante de Riñón/mortalidad , Obesidad/diagnóstico , Obesidad/mortalidad , Medición de Riesgo , Factores de Riesgo , Resultado del TratamientoRESUMEN
BACKGROUND: Waiting five to six minutes before measuring a train-of-four (TOF) after a 50-Hz tetanic stimulation or post-tetanic count (PTC) in order to allow the facilitation of transmission to subside is commonly recommended but is based on limited evidence. The purpose of this study was to measure the TOF responses after PTC in one hand and to compare the responses with those in the contralateral (control) hand. METHODS: Twenty-two adult patients undergoing elective surgery under opioid-desflurane anesthesia were fitted with sensors to measure displacement of their thumbs in response to ulnar nerve stimulation. Rocuronium 0.6 mg·kg(-1) was administered and TOF stimulation was applied to both sides. One side was randomized to PTC (50-Hz tetanus followed by a three-second pause and 15 1-Hz stimuli) when the opposite (control) side recovered to 10% first twitch (T1) height. Train-of-four stimulation was continued bilaterally every 20 sec until 30 min after PTC. Comparisons of the T1 and TOF ratio (T4/T1) were made at two, five, ten, 20, and 30 min. RESULTS: The mean (standard deviation [SD]) T1 value in the PTC arm was 11.8 (7.1)% just before PTC. The T1 values were significantly greater in the PTC arm at two, five, and ten minutes, with mean (SD) differences of 6.3 (6.7)%, 9.4 (6.8)%, and 7.4 (3.9)%, respectively (P = 0.008). There were no significant differences in T1 values between groups at 20 and 30 min, and no statistically significant differences in T4/T1 values at any time. CONCLUSION: A small but clinically insignificant increase in T1 is seen for at least ten minutes after PTC without any detectable change in T4/T1 values. The TOF responses are reliable as early as one minute after PTC.
Asunto(s)
Androstanoles/farmacología , Periodo de Recuperación de la Anestesia , Estimulación Eléctrica , Bloqueo Neuromuscular/métodos , Fármacos Neuromusculares no Despolarizantes/farmacología , Nervio Cubital/efectos de los fármacos , Adolescente , Adulto , Anciano , Femenino , Mano/inervación , Mano/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Rocuronio , Factores de Tiempo , Nervio Cubital/fisiopatología , Adulto JovenRESUMEN
Observing graft blood supply post kidney transplantation is essential. Compromised graft perfusion must be identified without delay to preserve organ survival. Implantable probes have revolutionised the graft monitoring process in kidney transplantation leading to safe, continuous, and distinct monitoring of blood supply. The Implantable Cook-Swartz Doppler Flow Monitoring System allows immediate salvaging of a compressed kidney. The implantable Doppler probe can easily and effectively identify such cases and save the limited number of organs that are available to today's patients.
Asunto(s)
Supervivencia de Injerto , Trasplante de Riñón/métodos , Riñón/irrigación sanguínea , Riñón/cirugía , Monitoreo Fisiológico/instrumentación , Complicaciones Posoperatorias/diagnóstico por imagen , Circulación Renal , Transductores , Ultrasonografía Doppler/instrumentación , Adulto , Velocidad del Flujo Sanguíneo , Diseño de Equipo , Femenino , Humanos , Donadores Vivos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/fisiopatología , Complicaciones Posoperatorias/cirugía , Valor Predictivo de las Pruebas , Flujo Sanguíneo Regional , Terapia Recuperativa , Factores de Tiempo , Resultado del TratamientoRESUMEN
Benign tumours of the bone are not cancerous and would not metastasise to other regions of the body. However, they can occur in any part of the skeleton, and can still be dangerous as they may grow and compress healthy bone tissue. There are several types of benign tumours that can be classified by the type of matrix that the tumour cells produce; such as bone, cartilage, fibrous tissue, fat or blood vessel. Overall, 8 different types can be distinguished: osteochondroma, osteoma, osteoid osteoma, osteoblastoma, giant cell tumour, aneurysmal bone cyst, fibrous dysplasia and enchondroma. The incidence of benign bone tumours varies depending on the type. However, they most commonly arise in people less than 30 years old, often triggered by the hormones that stimulate normal growth. The most common type is osteochondroma. This review discusses the different types of common benign tumours of the bone based on information accumulated from published literature.
RESUMEN
Developments in transplantation have progressed dramatically over the past century. Current research is underway to optimize immune modulation, genetically engineering animals for xenografting, and breakthroughs are occurring in regenerative medicine. However, pioneering live-donor transplantation has transformed transplantation in the organ shortage, and these contribute an increased proportion of transplanted organs. Live-donor transplantation is associated with better long-term outcomes, and techniques to recover organs have become less invasive. We set out to examine the evolution of transplantation from its historic beginnings to the developments that make it successful today.
Asunto(s)
Donadores Vivos/historia , Trasplante/historia , Animales , Rechazo de Injerto/historia , Rechazo de Injerto/prevención & control , Supervivencia de Injerto , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Inmunosupresores/historia , Inmunosupresores/uso terapéutico , Donadores Vivos/provisión & distribución , Trasplante/efectos adversos , Resultado del TratamientoRESUMEN
BACKGROUND: Surgical intervention is now the most effective modality with which to treat severe obesity. There is currently a lack of minimally invasive technology with which we can effectively treat obesity and reverse type 2 diabetes mellitus. The EndoBarrier is a fluoropolymer sleeve that is reversibly fixated to the duodenal bulb and extends 80 cm into the small bowel, usually terminating in the proximal jejunum. This endoscopically inserted device aids weight loss through malabsorption and activating hormonal triggers. METHODS: We conducted a nonsystematic review on worldwide articles published on the MEDLINE database to ascertain progress in the development and use of the EndoBarrier. RESULTS: Most studies used 12-week excess weight loss (EWL) as a primary outcome measure with results ranging from 11.9%-23.6%. One study to date used 52-week EWL as its primary measure with a significant outcome of 47%. Our group has seen this technology cause significant weight loss, resolution of type 2 diabetes mellitus, and improvement in cardiovascular risk factor profile. CONCLUSIONS: The EndoBarrier shows promise in the surgical weight loss arena. This review article summarizes the technical aspects of this new technology, provides preliminary efficacy results, and introduces the roles it may play in the future of bariatric surgery.
Asunto(s)
Diabetes Mellitus Tipo 2/cirugía , Duodeno/cirugía , Endoscopía Gastrointestinal/métodos , Yeyuno/cirugía , Obesidad Mórbida/cirugía , Anastomosis Quirúrgica/métodos , Remoción de Dispositivos , Diabetes Mellitus Tipo 2/complicaciones , Diseño de Equipo , Predicción , Humanos , Absorción Intestinal/fisiología , Obesidad Mórbida/complicaciones , Resultado del Tratamiento , Pérdida de Peso/fisiologíaRESUMEN
The routine use of ureteric stents after a kidney transplant for prophylactic measures is debatable. Concerns have been raised regarding the potential complications and costs of routine stenting. Here, we review the literature based on studies in favor of and against the routine placement of ureteric stents in kidney transplant patients. Some studies have shown a benefit to patients who have routine stents placed, while others have not shown this benefit but have highlighted the associated financial implications. The decision to stent renal transplant patients will depend on robust multicenter, randomized controlled trials being carried out, as well as both short-term and long-term cost analyses.